Related Experiment Videos
Lung transplantation for primary pulmonary hypertension
1Department of Medicine, Washington University School of Medicine, Lung Transplant Program Barnes-Jewish Hospital, St. Louis, Missouri, USA. trulockb@msnotes.wustl.edu
Clinics in Chest Medicine
|October 10, 2001
Summary
Lung transplantation remains crucial for severe pulmonary hypertension (PPH) unresponsive to medical therapy. Careful patient selection and timing are vital due to long waiting lists and the risk of chronic allograft rejection impacting long-term survival.
Area of Science:
- Pulmonary Medicine
- Transplantation Surgery
Background:
- Medical therapies for pulmonary hypertension (PPH) have advanced but are not universally effective.
- Some patients experience waning responses or drug-related side effects, limiting long-term treatment benefits.
Purpose of the Study:
- To highlight the continued importance of lung transplantation for severe PPH.
- To emphasize critical considerations in the transplant evaluation and referral process.
Main Methods:
- Review of current management strategies for PPH.
- Analysis of outcomes and challenges associated with lung and heart-lung transplantation for PPH.
Main Results:
- Lung transplantation is the definitive option for medically refractory severe PPH.
- Successful transplantation requires careful patient selection and timely referral, accounting for lengthy waiting periods.
- While functional recovery is excellent, long-term survival is challenged by chronic allograft rejection.
Conclusions:
- Lung transplantation remains a vital intervention for select PPH patients.
- Optimizing the transplant process, from initial referral to managing post-transplant complications like rejection, is essential for improving long-term outcomes.